SM

SG3 Management Portfolio holdings

AUM $6.45K
This Quarter Return
+0.57%
1 Year Return
-62.95%
3 Year Return
-60.35%
5 Year Return
-56.94%
10 Year Return
AUM
$158M
AUM Growth
+$158M
Cap. Flow
+$106M
Cap. Flow %
67.19%
Top 10 Hldgs %
77.02%
Holding
312
New
40
Increased
11
Reduced
14
Closed
52

Sector Composition

1 Consumer Discretionary 34.61%
2 Communication Services 23.44%
3 Technology 17.73%
4 Energy 7.41%
5 Healthcare 7.19%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ARQT icon
201
Arcutis Biotherapeutics
ARQT
$1.84B
-22,500
Closed -$479K
ATGE icon
202
Adtalem Global Education
ATGE
$4.76B
-2,500
Closed -$90K
ATHA icon
203
Athira Pharma
ATHA
$15.3M
0
AU icon
204
AngloGold Ashanti
AU
$29.3B
0
AUPH icon
205
Aurinia Pharmaceuticals
AUPH
$1.54B
0
AXSM icon
206
Axsome Therapeutics
AXSM
$6.16B
-4,000
Closed -$153K
AZN icon
207
AstraZeneca
AZN
$249B
0
BABA icon
208
Alibaba
BABA
$330B
0
BCS icon
209
Barclays
BCS
$68.7B
0
BEAM icon
210
Beam Therapeutics
BEAM
$1.65B
0
BEKE icon
211
KE Holdings
BEKE
$21.8B
-5,000
Closed -$90K
BHC icon
212
Bausch Health
BHC
$2.84B
-770,500
Closed -$6.44M
BIIB icon
213
Biogen
BIIB
$20.5B
0
BILI icon
214
Bilibili
BILI
$9.25B
0
BKR icon
215
Baker Hughes
BKR
$44.7B
0
BLMN icon
216
Bloomin' Brands
BLMN
$601M
0
BMRN icon
217
BioMarin Pharmaceuticals
BMRN
$11.3B
-10,300
Closed -$854K
BNTX icon
218
BioNTech
BNTX
$24.2B
-3,000
Closed -$447K
BOX icon
219
Box
BOX
$4.66B
-5,000
Closed -$126K
BRDG icon
220
Bridge Investment Group
BRDG
$455M
0
BRK.B icon
221
Berkshire Hathaway Class B
BRK.B
$1.08T
0
CCCC icon
222
C4 Therapeutics
CCCC
$179M
0
CCL icon
223
Carnival Corp
CCL
$42.2B
0
CELU icon
224
Celularity
CELU
$61.1M
0
CL icon
225
Colgate-Palmolive
CL
$68.2B
0